title: Two carboplatin-containing regimens for small cell lung cancer: preliminary results of a randomized phase II trial.
authors.affiliation: EORTC Lung Cancer Cooperative Group, Brussels, Belgium.
authors.forename: P E
authors.initials: PE
authors.lastname: Postmus
authors.forename: A
authors.initials: A
authors.lastname: Kirkpatrick
authors.forename: O
authors.initials: O
authors.lastname: Dalesio
authors.forename: F J
authors.initials: FJ
authors.lastname: Palmen
authors.forename: D N
authors.initials: DN
authors.lastname: Carney
authors.forename: J
authors.initials: J
authors.lastname: Festen
authors.forename: C
authors.initials: C
authors.lastname: Vendrik
authors.forename: K
authors.initials: K
authors.lastname: Roozendaal
authors.forename: J
authors.initials: J
authors.lastname: Burghouts
authors.forename: A
authors.initials: A
authors.lastname: Planting
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D004341:Drug Evaluation; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000188:drug therapy*; D009944:Organoplatinum Compounds / Q000008:administration & dosage*; D011897:Random Allocation; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D009944:Organoplatinum Compounds; D014750:Vincristine; D016190:Carboplatin; D007069:Ifosfamide